Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) | PAR 18 064

Opportunity Information: Apply for PAR 18 064

The Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) funding opportunity (PAR-18-064) is a National Institutes of Health (NIH) discretionary grant designed to move quickly when new, urgent substance use problems appear and researchers need to capture data before the moment passes. It uses the NIH R21 mechanism, which is typically meant for early-stage, pilot, feasibility, or exploratory studies rather than large, long-term projects. A key expectation is that applicants clearly justify why the proposed research question is time-sensitive and why a rapid review and expedited funding decision are necessary to answer it. In other words, this program is built for situations where waiting for a standard research cycle would mean missing a critical window to learn from a fast-changing event, policy shift, system change, or outbreak of harm.

The FOA targets five priority areas within substance use epidemiology and health services research. First, it supports rapid research responses to sudden and severe emerging drug issues, such as abrupt spikes in overdoses or poisonings linked to a specific substance (the example given is synthetic cannabinoids in a particular community). Second, it supports studies that respond to emerging marijuana trends, especially as laws and policies evolve and create new patterns of use, risk, availability, and health outcomes. Third, it funds time-sensitive opportunities in prescription drug abuse research, including situations created by new state or local initiatives, regulations, or program rollouts that can be evaluated only while they are being implemented or soon after. Fourth, it encourages research that takes advantage of unexpected and time-sensitive developments within medical and health care systems, such as changes in coverage, delivery models, or integration of addiction services, where understanding what is happening in real time can inform future practice and policy. Fifth, it supports research tied to criminal or juvenile justice system changes that affect drug use patterns or access to prevention and treatment, including structural reforms or new programs whose impacts are best measured during early implementation.

Because it is an R21, the opportunity is oriented toward generating actionable evidence quickly, often to inform follow-on studies or immediate decision-making. Projects under this mechanism may include pilot testing of measures, rapid analyses of emerging datasets, feasibility studies of interventions or service models, or natural experiment designs created by sudden policy or system shifts. The "clinical trial optional" designation means applicants may propose studies that include a clinical trial if appropriate, but a clinical trial is not required. The central theme is responsiveness: the research should be positioned to answer a pressing question that cannot wait.

The award information provided indicates an award ceiling of $200,000, reflecting the smaller, exploratory nature of R21 projects. The activity category is listed under education and health, with CFDA number 93.279, and the sponsoring agency is NIH. The original closing date shown is 2018-11-08, and the FOA creation date is 2017-11-08, which helps place this opportunity in time and suggests it was intended to address urgent developments during that period.

Eligibility is broad across U.S.-based organizations and government entities, which aligns with the goal of enabling rapid, locally informed research responses. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities/Indian housing authorities; Native American tribal organizations other than federally recognized tribal governments; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses) and small businesses; and additional categories listed as "others." The FOA also explicitly highlights eligibility for a range of mission-driven and community-connected institutions, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. At the same time, it restricts foreign participation: non-U.S. entities cannot apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as NIH defines them) are not allowed, reinforcing that the program is meant to support domestic rapid-response research capacity.

Overall, this FOA is essentially a rapid-response research lane for substance use and service systems questions that emerge unexpectedly and require quick mobilization. It emphasizes near-term, practical evidence generation in epidemiology and health services, with a strong requirement that applicants demonstrate why immediate funding and fast review are necessary to capture perishable information and produce findings that can guide public health, health care, and justice-system decisions.

• The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
• This funding opportunity was created on 2017-11-08.
• Applicants must submit their applications by 2018-11-08. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $200,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 18 064

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: